| Literature DB >> 3141076 |
J Jones1, B N Patel, C J Skidmore.
Abstract
Benzamides are potent inhibitors of nuclear ADP-ribosyltransferase and have been extensively used to demonstrate the involvement of ADP-ribosylation in cellular function. When permeabilized L1210 cells are treated with 50 microM 3-acetylamidobenzamide (3-aab) the enzyme is inhibited. However, when 50 nM 3-aab is used a two-fold stimulation of enzyme activity is produced. This anomalous stimulation is obtained with benzamides and nicotinamides and is correlated with their activity as inhibitors. Strikingly the steady-state level of poly(ADP-ribose) in intact cells is increased by these low levels of inhibitors. The mechanisms of this effect and its consequences for the experimental use of benzamides are discussed.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3141076 DOI: 10.1093/carcin/9.11.2023
Source DB: PubMed Journal: Carcinogenesis ISSN: 0143-3334 Impact factor: 4.944